1-methyltryptophan has been researched along with Central Nervous System Diseases in 1 studies
*Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dounay, AB; Tuttle, JB; Verhoest, PR | 1 |
1 review(s) available for 1-methyltryptophan and Central Nervous System Diseases
| Article | Year |
|---|---|
Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway.
Topics: Animals; Antineoplastic Agents; Central Nervous System Diseases; Enzyme Inhibitors; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Kynurenine 3-Monooxygenase; Signal Transduction; Transaminases | 2015 |